SpaceX Agrees to Merge With Cursor; Novo to File for China Approval of Wegovy; Dave & Buster's Misses Estimates

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- SpaceX (SPCX), X67 and Anysphere entered a merger agreement with Cursor in a deal which values Cursor at an implied equity value of $60b.
- Novo Nordisk (NOVOB DC) will submit oral Wegovy for regulatory approval in China in a few weeks, Chief Executive Officer Mike Doustdar told reporters in Beijing on Tuesday.
- Dave & Buster's (PLAY) reported revenue for the first quarter that missed the average analyst estimate.

See omnystudio.com/listener for privacy information.